Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.47 USD | +0.22% | +2.05% | +39.25% |
Mar. 18 | Allogene Therapeutics, Inc.(NasdaqGS:ALLO) added to S&P Biotechnology Select Industry Index | CI |
Mar. 15 | Allogene Therapeutics Files $500 Million Mixed Shelf | MT |
Financials (USD)
Sales 2024 * | 42.75K | Sales 2025 * | 4.12M | Capitalization | 754M |
---|---|---|---|---|---|
Net income 2024 * | -283M | Net income 2025 * | -305M | EV / Sales 2024 * | 11,793 x |
Net cash position 2024 * | 250M | Net cash position 2025 * | 142M | EV / Sales 2025 * | 149 x |
P/E ratio 2024 * |
-2.67
x | P/E ratio 2025 * |
-2.69
x | Employees | 233 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.49% |
Latest transcript on Allogene Therapeutics, Inc.
1 day | +0.22% | ||
1 week | +0.90% | ||
Current month | -8.96% | ||
1 month | -13.04% | ||
3 months | +39.69% | ||
6 months | +31.86% | ||
Current year | +39.25% |
Managers | Title | Age | Since |
---|---|---|---|
Joshua Kazam
FOU | Founder | 47 | 17-10-31 |
David Chang
FOU | Founder | 64 | 18-03-31 |
Geoffrey Parker
DFI | Director of Finance/CFO | 59 | 23-10-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Bonderman
BRD | Director/Board Member | 81 | 18-04-30 |
Joshua Kazam
FOU | Founder | 47 | 17-10-31 |
Arie Belldegrun
FOU | Founder | 74 | 17-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.54% | 2 M€ | -25.75% | ||
0.08% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 4.47 | +0.22% | 1,377,673 |
24-03-27 | 4.46 | +5.94% | 1,897,214 |
24-03-26 | 4.21 | -1.86% | 1,281,475 |
24-03-25 | 4.29 | +0.70% | 1,259,937 |
24-03-22 | 4.26 | -2.74% | 1,507,687 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.25% | 754M | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |